MSF urges pharmaceutical corporations to release clinical data to help develop urgently needed new TB regimens
NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access...
MSF and civil society urge Swiss negotiators not to undermine the ‘pharmacy of the developing world’
Nugzar Papashvili is an inpatient at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. He is in the fourth month of his latest treatment: this is the third time...
MSF launched for the first time an Antibiotic Resistance Study in Lashkar Gah, Helmand, Afghanistan in January 2013. Here, bacteria from collected specimens are grown on specific media before testing...
Last updated 27 February 2017
Last updated 23 February 2017
Last updated 14 February 2017
Last updated 7 February 2017
Pooja Iyer, MSF counselor, providing counseling to Hanif, an XDR-TB patient, in the MSF clinic in Mumbai. India 2016 © Atul Loke
Last updated 30 January 2017
Public Health Groups Welcome Johns Hopkins University and Medicines Patent Pool Agreement for Development of Promising New TB Drug
Medical staff work in the ambulatory ward at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. Georgia 2016 / Daro Sulakauri While deal marks a critical step...
Last updated 25 January 2017